<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>tumor microenvironment modeling &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tumor-microenvironment-modeling/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 15 Sep 2025 08:41:55 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>tumor microenvironment modeling &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Tumor-Derived Organoids from Circulating Cells: Unlocking Metastasis Mechanisms and Advancing Precision Medicine Platforms</title>
		<link>https://bioengineer.org/tumor-derived-organoids-from-circulating-cells-unlocking-metastasis-mechanisms-and-advancing-precision-medicine-platforms/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 15 Sep 2025 08:41:50 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CTC-derived organoids]]></category>
		<category><![CDATA[metastasis mechanisms]]></category>
		<category><![CDATA[microfluidic isolation techniques]]></category>
		<category><![CDATA[precision medicine platforms]]></category>
		<category><![CDATA[tumor microenvironment modeling]]></category>
		<guid isPermaLink="false">https://bioengineer.org/tumor-derived-organoids-from-circulating-cells-unlocking-metastasis-mechanisms-and-advancing-precision-medicine-platforms/</guid>

					<description><![CDATA[In the rapidly evolving landscape of cancer research, circulating tumor cells (CTCs) have emerged as pivotal players, offering unprecedented insights into tumor progression, metastasis, and therapeutic responses. These malignant cells, shed from both primary and metastatic tumor sites into the bloodstream, represent a dynamic reservoir of information that liquid biopsy technologies leverage to monitor cancer [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">269066</post-id>	</item>
	</channel>
</rss>
